セベラマー関連大腸炎が結腸癌を模倣する
Brittany Doll1, Chandler Shapiro1, Zoë Post2
1Rush University Medical Center, Department of Internal Medicine, Chicago, Illinois.
Gastro hep advances
|September 5, 2025
まとめ
セベラマー結晶は胃腸の損傷と隠れた出血を引き起こし,慢性腎臓病の患者では貧血が悪化する可能性があります. このケースは,末期性腎疾患の患者にこの原因を考慮することの重要性を強調しています.
科学分野:
- 腎臓科
- 胃腸内科
- 病理学について
背景:
- 末期腎疾患の患者はしばしばセベラマーのようなリン酸結合剤を必要とします.
- 貧血は慢性腎臓病患者の一般的な合併症です.
- 胃腸出血は貧血の潜在的な原因ですが,しばしば明らかな症状が表れます.
研究 の 目的:
- セベラマーを投与した末期腎疾患の患者の貧血を報告する.
- 原因不明の貧血と胃腸疾患の 原因を調べる
- 隠された出血の原因として,セベラマー結晶による胃腸粘膜損傷を強調する.
主な方法:
- セベラマーを投与した40歳の女性患者の症例報告
- 明らかに胃腸出血のない,急性または慢性貧血の臨床表現
- コロノスコーピーは の塊を明らかにした
- セベラマー結晶を示すバイオプシの組織病理学的検査
主要な成果:
- 患者は貧血が悪化していた.
- コロノスコーピーは 骨折しやすい 潰瘍の塊を示した
- バイオプシーは 炎症的変化とセベラマー結晶を 明らかにした
- セベラマー結晶の堆積が 粘膜損傷の原因と判明した.
結論:
- セベラマー結晶の堆積は胃腸粘膜の損傷を引き起こす可能性があります.
- セベラマー結晶による隠された胃腸出血は,慢性腎臓病の患者で貧血を引き起こす可能性があります.
- 臨床医は,原因不明の貧血と消化器系症状を有する患者の場合,セベラマー誘発の損傷を考慮する必要があります.
さらに関連する動画
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:25Assessment of the Rectum and Anus
399
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
399
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
308
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
308
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
140
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
140
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
680
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
680
01:21Barrett Esophagus-II: Clinical Manifestations and Management
290
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
290